• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.73% Nasdaq Down0.96%

    Qiagen NV (QGEN)

    -NasdaqGS
    27.10 Down 0.43(1.56%) Jul 27, 4:00PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Qiagen NV
    Spoorstraat 50
    Venlo, 5911 KJ
    Netherlands - Map
    Phone: 31 77 320 8400
    Fax: 31 77 320 8409
    Website: http://www.qiagen.com

    Details 
    Index Membership:N/A
    Sector:Services
    Industry:Research Services
    Full Time Employees:4,300

    Business Summary 

    QIAGEN N.V. provides sample to insight solutions that transform biological samples into valuable molecular insights worldwide. It offers sample technologies to isolate, purify, and stabilize nucleic acids and proteins in plasmid deoxyribonucleic acid (DNA) purification, ribonucleic acid purification and stabilization, genomic and viral nucleic acid purification, DNA cleanup after polymerase chain reaction (PCR) and sequencing, and library preparation for sequencing applications; and assay technologies to detect molecular targets. The company also offers ingenuity variant analysis, a cloud-based platform to evaluate data generated by NGS technologies; CLC cancer research workbench, a cancer-focused informatics solution; and GeneGlobe, a Web-based portal that enables researchers to search and select from pre-designed and custom PCR assay kits and NGS assay panels. In addition, it provides co-development, technology licenses and patent sales, and custom services, such as whole genome amplification services, DNA sequencing, and non-cGMP DNA production. Further, the company offers instrumentation systems for laboratories to perform nucleic acid sample preparation, assay setup, target detection, and interpretation of genomic information. Its automation platforms include QIAsymphony, a modular system; EZ1 Advanced XL for automated nucleic acid purification; QIAcube, a sample processing instrument; QIAcube HT for automated nucleic acid purification; Rotor-Gene Q, a rotary real-time PCR cycler system; PyroMark, a high-resolution detection platform; QIAgility, a compact benchtop instrument; QIAxcel for nucleic acid separation; and ESEQuant Tube Scanners. The company serves molecular diagnostics, applied testing, pharma, and academia customers. It has collaboration agreement with Astellas Pharma Inc., AstraZeneca PLC, Eli Lilly and Company, Exosome Diagnostics Inc., and Novartis AG. QIAGEN N.V. was founded in 1986 and is headquartered in Venlo, the Netherlands.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Qiagen NV

    Key Executives 
     PayExercised
    Mr. Peer M. Schatz , 50
    Chief Exec. Officer and Managing Director
    2.04M0.00
    Dr. Metin Colpan Ph.D., 60
    Co-Founder, Supervisory Director and Chairman of Science & Technology Committee
    63.00K0.00
    Dr. Roland Sackers , 47
    Chief Financial Officer and Managing Director
    945.00K0.00
    Mr. Douglas Liu ,
    Sr. VP of Global Operations
    N/AN/A
    Mr. John Gilardi ,
    VP of Corp. Communications & Investor Relations
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.